explore -WSS

explore

author：hotspot 2025-09-28 23:49:09 - browse：5691

Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Resistance to opioid

WSS

Readout Newsletter: Amylyx, Aurinia, and IQVIA

What is STAT's opinion section for?

Artificial intelligence use in health care faces greater scrutiny in 2024

Carbon Health diabetes program, a test of data

Having children helps parents live longer, especially after age 80

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

hotspot

explore

entertainment

Heart attack and stroke risk calculators need revising

Medical school prerequisites are outdated

Supreme Court strikes down use of affirmative action

Abbott's new heart device gets FDA advisory panel nod

How to save PrEP access — and even expand it

Abbott's new heart device gets FDA advisory panel nod

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Juul documents reveal insider tactics on political lobbying

Virginia high school admissions case could be legal follow

Long Covid research funding gets a major boost from NIH

hotspot

FDA reorg will put new emphasis on investigations, sources say

Why Eli Lilly’s earnings didn’t quite live up to the hype

What health policies could hitch a ride on a spending bill?

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Today's health inequities arise from racist U.S. history, say experts

Experimental asthma app from Apple and Anthem shows promise

explore

Wikipedia

hotspot

hotspot